Identification of ubiquitination-related hub genes in chronic myeloid leukemia cell by bioinformatics analysis

Qian Zhou1,2,3, Zhuoran Li1,2,3, Li Meng1,2,3

  • 1Key Lab of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Journal of Cancer
|June 24, 2024
PubMed

Insights

This study identifies UHRF1 and CDC20 as key ubiquitination-related genes in chronic myeloid leukemia stem cells (CML-LSCs). Targeting these genes may offer a new strategy to eradicate CML-LSCs and overcome treatment resistance.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Chronic myeloid leukemia stem cells (CML-LSCs) drive TKI resistance and CML recurrence.
  • Ubiquitination is implicated in CML progression, but its specific role in CML-LSCs requires further elucidation.

Purpose of the Study:

  • To identify potential ubiquitination-related genes in CML-LSCs through bioinformatics analysis.
  • To explore these genes as therapeutic targets for eradicating CML-LSCs.

Main Methods:

  • Differential gene expression analysis of ubiquitination-related genes between normal HSCs and CML-LSCs.
  • Protein-protein interaction network analysis to identify hub genes.
  • Analysis of upstream regulatory networks (transcription factors and microRNAs).
  • Correlation analysis with immune cell infiltration and functional validation in CML models.

Main Results:

  • Four hub ubiquitination-related genes (AURKA, Fancd2, Cdc20, Uhrf1) were identified and associated with immune cell infiltration in LSCs.
  • UHRF1 and CDC20 were found to be highly expressed in CML-LSCs.
  • Knockdown of Fancd2, Cdc20, and Uhrf1 significantly inhibited CML cell proliferation.

Conclusions:

  • UHRF1 and CDC20 are novel key ubiquitination-related genes in CML-LSCs.
  • These genes play a significant role in the pathogenesis of CML.
  • Targeting UHRF1 and CDC20 presents a potential therapeutic strategy for CML.